Brown & Brown (BRO) is back in focus after its second quarter 2026 adjusted earnings missed estimates, with management highlighting weak organic growth and mixed performance between the retail and specialty distribution segments.
Over the past quarter, Brown & Brown has seen a 90 day share price return of 28.04%, even though the year to date share price return is down 6.24% and the 1 year total shareholder return is down 23.53%. This suggests that recent momentum may be rebuilding after a weaker stretch.
Compare Brown & Brown's recent setback with other insurers showing stronger momentum and financial resilience by scanning the hand picked list of solid balance sheet and fundamentals (51 results).
Brown & Brown now trades at a discount to both intrinsic value estimates and the average analyst target, even after the sharp rebound. Is the market rightly cautious after the earnings miss, or is it marking the stock down too far ahead of a valuation check?
Most Popular Narrative: 3.8% Undervalued
Brown & Brown's most followed narrative points to a fair value of $75.63 versus the last close at $72.78. This frames the current discount as modest but meaningful.
Strong cash flow from operations, combined with a strategic focus on leveraging a diversified portfolio across geographies and lines of business, positions the company to navigate economic uncertainties and potentially increase future earnings stability and growth.
Want to understand why this narrative still arrives at a premium to the current price? It leans heavily on measured revenue growth, firm but slightly lower margins, and a richer future earnings multiple that assumes investors will keep paying up for Brown & Brown's profile.
The fair value uses a discount rate of 7.11% and ties together expectations for moderate top line growth, a small step down in profitability, and a higher implied P/E in later years. Analysts behind this narrative are effectively saying the market is weighing slower growth against steady earnings and still assigning Brown & Brown a quality premium.
Result: Fair Value of $75.63 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Brown & Brown's narrative could be tested if revenue growth slows further, or if rising costs in areas like employee benefits compress margins more than expected.
Find out about the key risks to this Brown & Brown narrative.
Another View on Brown & Brown's Valuation
The narrative fair value for Brown & Brown points to a modest 3.8% discount. Yet on simple earnings multiples the picture looks very different. Brown & Brown trades on a P/E of 20.4x, which is higher than the US Insurance industry at 11.4x and above a fair ratio of 13.4x, while still below a peer average of 34.1x. That mix of richer pricing than the sector but cheaper than closer peers raises a practical question for investors about how much valuation risk they are willing to accept for this profile.
To see how those earnings multiples stack up against detailed valuation work, it helps to review the full breakdown in our fair ratio analysis for Brown & Brown, including how the market could move toward that ratio over time, in the See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Given the mixed signals around Brown & Brown, this is a moment to look closely at both sides of the story and move from headlines to your own assessment. To weigh up what concerns other investors and what they see as the upside, start by reviewing the 2 key rewards and 2 important warning signs.
Looking for more investment ideas beyond Brown & Brown?
If you stop with Brown & Brown, you could miss other opportunities that better fit your goals, risk comfort, or income needs on Simply Wall Street's screener.
- Target potential value opportunities by scanning the 51 high quality undervalued stocks that match strong fundamentals with prices that may not fully reflect them.
- Strengthen your income stream by reviewing the 11 dividend fortresses that focus on higher yields with an emphasis on resilience.
- Dial back portfolio risk by assessing the 75 resilient stocks with low risk scores that score well on financial stability and downside protection.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com